![]() Hunan Nucien Pharmaceutical Hunan Nucien Pharmaceutical (湖南南新制药股份有限公司) is a manufacturer and supplier of
Pharmaceutical products. | ![]() GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | ![]() Shanghai Shenqi Pharmaceutical Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine. | Guizhou Sanli Pharmaceutical Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products. | ||
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 1980 | Founding Date 1983 | Founding Date 1995 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Chang Sha Shi, CN HQ | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Bengaluru, IN HQ | Locations Shanghai, CN HQ | Locations An Shun Shi, CN HQ |
Employees | Employees N/A | Employees 68,629 | Employees 5341% decrease | Employees 1,26611% decrease | Employees 2,85225% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) N/A | Valuation ($) 571.4 m | Valuation ($) 796.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥258.4m (FY, 2024) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥2b (FY, 2024) | Revenue (est.) ¥2.1b (FY, 2024) |
Cost of goods | Cost of goods ¥119.6m (FY, 2024) | Cost of goods £5.6b (FY, 2025) | Cost of goods N/A | Cost of goods ¥1.1b (FY, 2024) | Cost of goods ¥650m (FY, 2024) |
Gross profit | Gross profit ¥138.9m (FY, 2024) | Gross profit £28.5b (FY, 2025) | Gross profit N/A | Gross profit ¥946.8m (FY, 2024) | Gross profit ¥1.5b (FY, 2024) |
Net income | Net income (¥397.3m) (FY, 2024) | Net income £6.3b (FY, 2025) | Net income N/A | Net income ¥66.1m (FY, 2024) | Net income ¥279.8m (FY, 2024) |

GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company
Kemwell Biopharma is a contract biologic development company.
View company
Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine.
View companyGuizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products.
View company